Atlas Trials

One Year Results of Switching to Aflibercept for Persistent Diabetic Macular Edema Resistant to Bevacizumab

Clinical trial NCT03974425 · COMPLETED

Trial details

NCT number
NCT03974425
Sponsor
University of Alexandria
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetic Macular Edema
Start date
2016-04-01
Primary completion
2017-04-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.